Gene Ontology terms associated with a binding site
- Binding site
- Motif_639
- Name
- WRKY18
- Description
- Identification of genes encoding receptor-like protein kinases as possible targets of pathogen- and salicylic acid-induced WRKY DNA-binding proteins in Arabidopsis
- #Associated genes
- 80
- #Associated GO terms
- 604
Biological Process
Molecular Function
Cellular Component
Molecular Function (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005488 | binding | 67 (83.75%) | 3 | 8 | 5 | 10 | 6 | 13 | 5 | 5 | 4 | 8 |
GO:1901363 | heterocyclic compound binding | 42 (52.50%) | 2 | 4 | 3 | 6 | 5 | 6 | 2 | 4 | 3 | 7 |
GO:0097159 | organic cyclic compound binding | 42 (52.50%) | 2 | 4 | 3 | 6 | 5 | 6 | 2 | 4 | 3 | 7 |
GO:0043167 | ion binding | 37 (46.25%) | 3 | 5 | 4 | 5 | 3 | 6 | 3 | 2 | 2 | 4 |
GO:0005515 | protein binding | 36 (45.00%) | 2 | 5 | 3 | 4 | 3 | 8 | 2 | 3 | 2 | 4 |
GO:0003824 | catalytic activity | 35 (43.75%) | 3 | 5 | 3 | 5 | 2 | 5 | 2 | 4 | 3 | 3 |
GO:0097367 | carbohydrate derivative binding | 29 (36.25%) | 2 | 4 | 3 | 5 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:1901265 | nucleoside phosphate binding | 29 (36.25%) | 2 | 4 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 4 |
GO:0000166 | nucleotide binding | 29 (36.25%) | 2 | 4 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 4 |
GO:0036094 | small molecule binding | 29 (36.25%) | 2 | 4 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 4 |
GO:0030554 | adenyl nucleotide binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0032559 | adenyl ribonucleotide binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0043168 | anion binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0001882 | nucleoside binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0001883 | purine nucleoside binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0017076 | purine nucleotide binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0032550 | purine ribonucleoside binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0032555 | purine ribonucleotide binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0032549 | ribonucleoside binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0032553 | ribonucleotide binding | 28 (35.00%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 4 |
GO:0005524 | ATP binding | 26 (32.50%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 2 |
GO:0035639 | purine ribonucleoside triphosphate binding | 26 (32.50%) | 2 | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 2 | 2 |
GO:0016301 | kinase activity | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0016740 | transferase activity | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0004672 | protein kinase activity | 23 (28.75%) | 2 | 4 | 2 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0004674 | protein serine/threonine kinase activity | 17 (21.25%) | 1 | 4 | 1 | 3 | 0 | 3 | 0 | 2 | 2 | 1 |
GO:0003676 | nucleic acid binding | 15 (18.75%) | 0 | 0 | 0 | 2 | 2 | 3 | 1 | 2 | 1 | 4 |
GO:0003677 | DNA binding | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0043169 | cation binding | 9 (11.25%) | 1 | 1 | 1 | 1 | 0 | 3 | 2 | 0 | 0 | 0 |
GO:0046872 | metal ion binding | 9 (11.25%) | 1 | 1 | 1 | 1 | 0 | 3 | 2 | 0 | 0 | 0 |
GO:0001071 | nucleic acid binding transcription factor activity | 9 (11.25%) | 0 | 0 | 0 | 0 | 3 | 2 | 0 | 2 | 1 | 1 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9 (11.25%) | 0 | 0 | 0 | 0 | 3 | 2 | 0 | 2 | 1 | 1 |
GO:0043565 | sequence-specific DNA binding | 8 (10.00%) | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 1 |
GO:0016787 | hydrolase activity | 7 (8.75%) | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
GO:0046914 | transition metal ion binding | 6 (7.50%) | 1 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 |
GO:0000975 | regulatory region DNA binding | 5 (6.25%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 1 |
GO:0001067 | regulatory region nucleic acid binding | 5 (6.25%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 1 |
GO:0044212 | transcription regulatory region DNA binding | 5 (6.25%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 1 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 5 (6.25%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 1 |
GO:0004713 | protein tyrosine kinase activity | 4 (5.00%) | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008270 | zinc ion binding | 4 (5.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0043531 | ADP binding | 3 (3.75%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
GO:0016881 | acid-amino acid ligase activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0016874 | ligase activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
GO:0060089 | molecular transducer activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0004872 | receptor activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0004871 | signal transducer activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0038023 | signaling receptor activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0019787 | small conjugating protein ligase activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
GO:0022892 | substrate-specific transporter activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0019199 | transmembrane receptor protein kinase activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0004888 | transmembrane signaling receptor activity | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
GO:0005215 | transporter activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0004842 | ubiquitin-protein ligase activity | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
GO:0003723 | RNA binding | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0008324 | cation transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0003682 | chromatin binding | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
GO:0005507 | copper ion binding | 2 (2.50%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0004126 | cytidine deaminase activity | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0019239 | deaminase activity | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0030234 | enzyme regulator activity | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016798 | hydrolase activity, acting on glycosyl bonds | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0022890 | inorganic cation transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0015075 | ion transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0016298 | lipase activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0046873 | metal ion transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0019208 | phosphatase regulator activity | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0015079 | potassium ion transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0019888 | protein phosphatase regulator activity | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0008601 | protein phosphatase type 2A regulator activity | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0022891 | substrate-specific transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0022857 | transmembrane transporter activity | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008026 | ATP-dependent helicase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016887 | ATPase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0042623 | ATPase activity, coupled | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0022804 | active transmembrane transporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004556 | alpha-amylase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0016160 | amylase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005509 | calcium ion binding | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0030246 | carbohydrate binding | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0008061 | chitin binding | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004568 | chitinase activity | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004519 | endonuclease activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0004521 | endoribonuclease activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0004386 | helicase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0004518 | nuclease activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0017111 | nucleoside-triphosphatase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0045735 | nutrient reservoir activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004620 | phospholipase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0008266 | poly(U) RNA binding | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008187 | poly-pyrimidine tract binding | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0022820 | potassium ion symporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009674 | potassium:sodium symporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0046983 | protein dimerization activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008565 | protein transporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070035 | purine NTP-dependent helicase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016462 | pyrophosphatase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005102 | receptor binding | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033612 | receptor serine/threonine kinase binding | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004525 | ribonuclease III activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0004540 | ribonuclease activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0015291 | secondary active transmembrane transporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0003727 | single-stranded RNA binding | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0015293 | symporter activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0008134 | transcription factor binding | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004675 | transmembrane receptor protein serine/threonine kinase activity | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004714 | transmembrane receptor protein tyrosine kinase activity | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cellular Component (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005623 | cell | 27 (33.75%) | 2 | 3 | 2 | 2 | 0 | 6 | 2 | 3 | 3 | 4 |
GO:0044464 | cell part | 27 (33.75%) | 2 | 3 | 2 | 2 | 0 | 6 | 2 | 3 | 3 | 4 |
GO:0005622 | intracellular | 19 (23.75%) | 0 | 2 | 0 | 2 | 0 | 5 | 2 | 2 | 2 | 4 |
GO:0044424 | intracellular part | 18 (22.50%) | 0 | 2 | 0 | 2 | 0 | 4 | 2 | 2 | 2 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 14 (17.50%) | 0 | 1 | 0 | 2 | 0 | 3 | 2 | 1 | 1 | 4 |
GO:0043229 | intracellular organelle | 14 (17.50%) | 0 | 1 | 0 | 2 | 0 | 3 | 2 | 1 | 1 | 4 |
GO:0043227 | membrane-bounded organelle | 14 (17.50%) | 0 | 1 | 0 | 2 | 0 | 3 | 2 | 1 | 1 | 4 |
GO:0043226 | organelle | 14 (17.50%) | 0 | 1 | 0 | 2 | 0 | 3 | 2 | 1 | 1 | 4 |
GO:0016020 | membrane | 13 (16.25%) | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 2 | 2 | 2 |
GO:0005634 | nucleus | 11 (13.75%) | 0 | 0 | 0 | 2 | 0 | 3 | 1 | 1 | 1 | 3 |
GO:0071944 | cell periphery | 10 (12.50%) | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
GO:0005737 | cytoplasm | 10 (12.50%) | 0 | 2 | 0 | 1 | 0 | 1 | 2 | 1 | 1 | 2 |
GO:0005886 | plasma membrane | 9 (11.25%) | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0044444 | cytoplasmic part | 8 (10.00%) | 0 | 2 | 0 | 1 | 0 | 1 | 2 | 0 | 0 | 2 |
GO:0005829 | cytosol | 5 (6.25%) | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
GO:1902494 | catalytic complex | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0030054 | cell junction | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0005911 | cell-cell junction | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0032991 | macromolecular complex | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0009506 | plasmodesma | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0043234 | protein complex | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0055044 | symplast | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0009507 | chloroplast | 2 (2.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0042579 | microbody | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005777 | peroxisome | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009536 | plastid | 2 (2.50%) | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0000159 | protein phosphatase type 2A complex | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0008287 | protein serine/threonine phosphatase complex | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0048046 | apoplast | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005618 | cell wall | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0012505 | endomembrane system | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005783 | endoplasmic reticulum | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031975 | envelope | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0030312 | external encapsulating structure | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005576 | extracellular region | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0016021 | integral to membrane | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070013 | intracellular organelle lumen | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044446 | intracellular organelle part | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031224 | intrinsic to membrane | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044425 | membrane part | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031974 | membrane-enclosed lumen | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005739 | mitochondrion | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043228 | non-membrane-bounded organelle | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005635 | nuclear envelope | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031981 | nuclear lumen | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044428 | nuclear part | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005730 | nucleolus | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031967 | organelle envelope | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043233 | organelle lumen | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044422 | organelle part | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0048471 | perinuclear region of cytoplasm | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0000151 | ubiquitin ligase complex | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Biological Process (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0009987 | cellular process | 60 (75.00%) | 3 | 6 | 4 | 8 | 6 | 9 | 3 | 7 | 6 | 8 |
GO:0044237 | cellular metabolic process | 51 (63.75%) | 3 | 6 | 4 | 8 | 4 | 8 | 2 | 6 | 4 | 6 |
GO:0008152 | metabolic process | 51 (63.75%) | 3 | 6 | 4 | 8 | 4 | 8 | 2 | 6 | 4 | 6 |
GO:0071704 | organic substance metabolic process | 51 (63.75%) | 3 | 6 | 4 | 8 | 4 | 8 | 2 | 6 | 4 | 6 |
GO:0044238 | primary metabolic process | 50 (62.50%) | 3 | 6 | 4 | 7 | 4 | 8 | 2 | 6 | 4 | 6 |
GO:0044260 | cellular macromolecule metabolic process | 45 (56.25%) | 2 | 5 | 4 | 7 | 4 | 7 | 2 | 5 | 3 | 6 |
GO:0043170 | macromolecule metabolic process | 45 (56.25%) | 2 | 5 | 4 | 7 | 4 | 7 | 2 | 5 | 3 | 6 |
GO:0044699 | single-organism process | 34 (42.50%) | 3 | 5 | 4 | 5 | 2 | 4 | 2 | 4 | 3 | 2 |
GO:0044267 | cellular protein metabolic process | 30 (37.50%) | 2 | 5 | 4 | 5 | 2 | 4 | 1 | 3 | 2 | 2 |
GO:0019538 | protein metabolic process | 30 (37.50%) | 2 | 5 | 4 | 5 | 2 | 4 | 1 | 3 | 2 | 2 |
GO:0044763 | single-organism cellular process | 30 (37.50%) | 3 | 4 | 3 | 4 | 2 | 3 | 2 | 4 | 3 | 2 |
GO:0043412 | macromolecule modification | 29 (36.25%) | 2 | 5 | 3 | 5 | 2 | 4 | 1 | 3 | 2 | 2 |
GO:0006464 | cellular protein modification process | 28 (35.00%) | 2 | 5 | 3 | 5 | 2 | 4 | 1 | 3 | 2 | 1 |
GO:0036211 | protein modification process | 28 (35.00%) | 2 | 5 | 3 | 5 | 2 | 4 | 1 | 3 | 2 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0006793 | phosphorus metabolic process | 24 (30.00%) | 2 | 4 | 3 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0016310 | phosphorylation | 23 (28.75%) | 2 | 4 | 2 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0006468 | protein phosphorylation | 23 (28.75%) | 2 | 4 | 2 | 4 | 2 | 3 | 1 | 2 | 2 | 1 |
GO:0009058 | biosynthetic process | 21 (26.25%) | 1 | 1 | 1 | 2 | 2 | 4 | 0 | 4 | 2 | 4 |
GO:0044249 | cellular biosynthetic process | 21 (26.25%) | 1 | 1 | 1 | 2 | 2 | 4 | 0 | 4 | 2 | 4 |
GO:1901576 | organic substance biosynthetic process | 21 (26.25%) | 1 | 1 | 1 | 2 | 2 | 4 | 0 | 4 | 2 | 4 |
GO:0065007 | biological regulation | 20 (25.00%) | 2 | 1 | 1 | 2 | 2 | 4 | 1 | 2 | 1 | 4 |
GO:0050789 | regulation of biological process | 20 (25.00%) | 2 | 1 | 1 | 2 | 2 | 4 | 1 | 2 | 1 | 4 |
GO:0050794 | regulation of cellular process | 19 (23.75%) | 2 | 1 | 1 | 2 | 2 | 4 | 1 | 2 | 1 | 3 |
GO:0034645 | cellular macromolecule biosynthetic process | 18 (22.50%) | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 3 | 1 | 4 |
GO:0009059 | macromolecule biosynthetic process | 18 (22.50%) | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 3 | 1 | 4 |
GO:0050896 | response to stimulus | 18 (22.50%) | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 4 |
GO:0006807 | nitrogen compound metabolic process | 17 (21.25%) | 1 | 1 | 0 | 3 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0006725 | cellular aromatic compound metabolic process | 16 (20.00%) | 2 | 1 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:1901360 | organic cyclic compound metabolic process | 16 (20.00%) | 2 | 1 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0034641 | cellular nitrogen compound metabolic process | 15 (18.75%) | 1 | 1 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0046483 | heterocycle metabolic process | 15 (18.75%) | 1 | 1 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0032501 | multicellular organismal process | 15 (18.75%) | 1 | 3 | 0 | 4 | 1 | 2 | 0 | 2 | 1 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 15 (18.75%) | 1 | 1 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0006950 | response to stress | 15 (18.75%) | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 2 | 1 | 4 |
GO:0044707 | single-multicellular organism process | 15 (18.75%) | 1 | 3 | 0 | 4 | 1 | 2 | 0 | 2 | 1 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 14 (17.50%) | 1 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:1901362 | organic cyclic compound biosynthetic process | 14 (17.50%) | 1 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0044710 | single-organism metabolic process | 14 (17.50%) | 2 | 2 | 2 | 2 | 0 | 1 | 1 | 2 | 1 | 1 |
GO:0032774 | RNA biosynthetic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0016070 | RNA metabolic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0010467 | gene expression | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0018130 | heterocycle biosynthetic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0090304 | nucleic acid metabolic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0010468 | regulation of gene expression | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0060255 | regulation of macromolecule metabolic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0019222 | regulation of metabolic process | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0006351 | transcription, DNA-templated | 13 (16.25%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 4 |
GO:0006952 | defense response | 12 (15.00%) | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 3 |
GO:2001141 | regulation of RNA biosynthetic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0051252 | regulation of RNA metabolic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0009889 | regulation of biosynthetic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0031326 | regulation of cellular biosynthetic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0031323 | regulation of cellular metabolic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0051171 | regulation of nitrogen compound metabolic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0080090 | regulation of primary metabolic process | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0006355 | regulation of transcription, DNA-dependent | 12 (15.00%) | 0 | 0 | 0 | 1 | 2 | 3 | 0 | 2 | 1 | 3 |
GO:0032502 | developmental process | 11 (13.75%) | 1 | 2 | 0 | 2 | 1 | 2 | 0 | 1 | 1 | 1 |
GO:0007275 | multicellular organismal development | 11 (13.75%) | 1 | 2 | 0 | 2 | 1 | 2 | 0 | 1 | 1 | 1 |
GO:0044767 | single-organism developmental process | 11 (13.75%) | 1 | 2 | 0 | 2 | 1 | 2 | 0 | 1 | 1 | 1 |
GO:0048856 | anatomical structure development | 9 (11.25%) | 1 | 1 | 0 | 2 | 1 | 2 | 0 | 1 | 1 | 0 |
GO:0051704 | multi-organism process | 9 (11.25%) | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 2 | 1 | 1 |
GO:0000003 | reproduction | 9 (11.25%) | 1 | 2 | 0 | 3 | 1 | 1 | 0 | 1 | 0 | 0 |
GO:0022414 | reproductive process | 9 (11.25%) | 1 | 2 | 0 | 3 | 1 | 1 | 0 | 1 | 0 | 0 |
GO:0042221 | response to chemical | 9 (11.25%) | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 |
GO:0007154 | cell communication | 8 (10.00%) | 2 | 1 | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 |
GO:0048519 | negative regulation of biological process | 8 (10.00%) | 2 | 1 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 7 (8.75%) | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0008219 | cell death | 7 (8.75%) | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 |
GO:0051716 | cellular response to stimulus | 7 (8.75%) | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
GO:0016265 | death | 7 (8.75%) | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 |
GO:0009791 | post-embryonic development | 7 (8.75%) | 1 | 1 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 1 |
GO:0048731 | system development | 7 (8.75%) | 1 | 1 | 0 | 2 | 1 | 2 | 0 | 0 | 0 | 0 |
GO:0005975 | carbohydrate metabolic process | 6 (7.50%) | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
GO:0051234 | establishment of localization | 6 (7.50%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 1 |
GO:0051179 | localization | 6 (7.50%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 1 |
GO:0009311 | oligosaccharide metabolic process | 6 (7.50%) | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
GO:0031347 | regulation of defense response | 6 (7.50%) | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048583 | regulation of response to stimulus | 6 (7.50%) | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0080134 | regulation of response to stress | 6 (7.50%) | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010033 | response to organic substance | 6 (7.50%) | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 2 |
GO:0044723 | single-organism carbohydrate metabolic process | 6 (7.50%) | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
GO:0044765 | single-organism transport | 6 (7.50%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 1 |
GO:0044281 | small molecule metabolic process | 6 (7.50%) | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006810 | transport | 6 (7.50%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 1 |
GO:0009056 | catabolic process | 5 (6.25%) | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0048610 | cellular process involved in reproduction | 5 (6.25%) | 0 | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
GO:0098542 | defense response to other organism | 5 (6.25%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0003006 | developmental process involved in reproduction | 5 (6.25%) | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0048513 | organ development | 5 (6.25%) | 1 | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
GO:1901575 | organic substance catabolic process | 5 (6.25%) | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0048608 | reproductive structure development | 5 (6.25%) | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0061458 | reproductive system development | 5 (6.25%) | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0009628 | response to abiotic stimulus | 5 (6.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 |
GO:0009607 | response to biotic stimulus | 5 (6.25%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0051707 | response to other organism | 5 (6.25%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:1901700 | response to oxygen-containing compound | 5 (6.25%) | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0048367 | shoot system development | 5 (6.25%) | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
GO:0044702 | single organism reproductive process | 5 (6.25%) | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0006491 | N-glycan processing | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009838 | abscission | 4 (5.00%) | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0019752 | carboxylic acid metabolic process | 4 (5.00%) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006812 | cation transport | 4 (5.00%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0008037 | cell recognition | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0044248 | cellular catabolic process | 4 (5.00%) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070887 | cellular response to chemical stimulus | 4 (5.00%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0009908 | flower development | 4 (5.00%) | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0009101 | glycoprotein biosynthetic process | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009100 | glycoprotein metabolic process | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0070085 | glycosylation | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006955 | immune response | 4 (5.00%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0002376 | immune system process | 4 (5.00%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0045087 | innate immune response | 4 (5.00%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0006811 | ion transport | 4 (5.00%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0043413 | macromolecule glycosylation | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0030001 | metal ion transport | 4 (5.00%) | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0044706 | multi-multicellular organism process | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0044703 | multi-organism reproductive process | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006082 | organic acid metabolic process | 4 (5.00%) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901564 | organonitrogen compound metabolic process | 4 (5.00%) | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043436 | oxoacid metabolic process | 4 (5.00%) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009875 | pollen-pistil interaction | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0009856 | pollination | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006487 | protein N-linked glycosylation | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0006486 | protein glycosylation | 4 (5.00%) | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0048544 | recognition of pollen | 4 (5.00%) | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0010941 | regulation of cell death | 4 (5.00%) | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0050793 | regulation of developmental process | 4 (5.00%) | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009737 | response to abscisic acid | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0097305 | response to alcohol | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0009719 | response to endogenous stimulus | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0009725 | response to hormone | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0010035 | response to inorganic substance | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0033993 | response to lipid | 4 (5.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 |
GO:0007165 | signal transduction | 4 (5.00%) | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0023052 | signaling | 4 (5.00%) | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044700 | single organism signaling | 4 (5.00%) | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044711 | single-organism biosynthetic process | 4 (5.00%) | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:1901136 | carbohydrate derivative catabolic process | 3 (3.75%) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046394 | carboxylic acid biosynthetic process | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0048869 | cellular developmental process | 3 (3.75%) | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
GO:0044255 | cellular lipid metabolic process | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0051607 | defense response to virus | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0010227 | floral organ abscission | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048437 | floral organ development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048229 | gametophyte development | 3 (3.75%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0002252 | immune effector process | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0006629 | lipid metabolic process | 3 (3.75%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009057 | macromolecule catabolic process | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0032787 | monocarboxylic acid metabolic process | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0031348 | negative regulation of defense response | 3 (3.75%) | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051093 | negative regulation of developmental process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060862 | negative regulation of floral organ abscission | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:2000242 | negative regulation of reproductive process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048585 | negative regulation of response to stimulus | 3 (3.75%) | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016053 | organic acid biosynthetic process | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901565 | organonitrogen compound catabolic process | 3 (3.75%) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048518 | positive regulation of biological process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010942 | positive regulation of cell death | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048522 | positive regulation of cellular process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031349 | positive regulation of defense response | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048584 | positive regulation of response to stimulus | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048569 | post-embryonic organ development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0012501 | programmed cell death | 3 (3.75%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0060860 | regulation of floral organ abscission | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009909 | regulation of flower development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:2000026 | regulation of multicellular organismal development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0051239 | regulation of multicellular organismal process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048580 | regulation of post-embryonic development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:2000241 | regulation of reproductive process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048831 | regulation of shoot system development | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0046686 | response to cadmium ion | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0010038 | response to metal ion | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
GO:0006970 | response to osmotic stress | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
GO:0009651 | response to salt stress | 3 (3.75%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
GO:0009615 | response to virus | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
GO:0044712 | single-organism catabolic process | 3 (3.75%) | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044283 | small molecule biosynthetic process | 3 (3.75%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0055085 | transmembrane transport | 3 (3.75%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
GO:0009653 | anatomical structure morphogenesis | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0019439 | aromatic compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0030154 | cell differentiation | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044262 | cellular carbohydrate metabolic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044270 | cellular nitrogen compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071804 | cellular potassium ion transport | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0036294 | cellular response to decreased oxygen levels | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0071456 | cellular response to hypoxia | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0071407 | cellular response to organic cyclic compound | 2 (2.50%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0071310 | cellular response to organic substance | 2 (2.50%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0071453 | cellular response to oxygen levels | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0033554 | cellular response to stress | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006216 | cytidine catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009972 | cytidine deamination | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046087 | cytidine metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0005984 | disaccharide metabolic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0009913 | epidermal cell differentiation | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008544 | epidermis development | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0030855 | epithelial cell differentiation | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060429 | epithelium development | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006633 | fatty acid biosynthetic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006631 | fatty acid metabolic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901658 | glycosyl compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901657 | glycosyl compound metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046700 | heterocycle catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0034050 | host programmed cell death induced by symbiont | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0034220 | ion transmembrane transport | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0008610 | lipid biosynthetic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0015672 | monovalent inorganic cation transport | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0048523 | negative regulation of cellular process | 2 (2.50%) | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010629 | negative regulation of gene expression | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009892 | negative regulation of metabolic process | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009164 | nucleoside catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009116 | nucleoside metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901361 | organic cyclic compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031408 | oxylipin biosynthetic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0031407 | oxylipin metabolic process | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009626 | plant-type hypersensitive response | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009555 | pollen development | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0071805 | potassium ion transmembrane transport | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006813 | potassium ion transport | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0046135 | pyrimidine nucleoside catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006213 | pyrimidine nucleoside metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046133 | pyrimidine ribonucleoside catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0072529 | pyrimidine-containing compound catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0072527 | pyrimidine-containing compound metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0036293 | response to decreased oxygen levels | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0001666 | response to hypoxia | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901698 | response to nitrogen compound | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0014070 | response to organic cyclic compound | 2 (2.50%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070482 | response to oxygen levels | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009611 | response to wounding | 2 (2.50%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
GO:0042454 | ribonucleoside catabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009119 | ribonucleoside metabolic process | 2 (2.50%) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043588 | skin development | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009888 | tissue development | 2 (2.50%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006305 | DNA alkylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006259 | DNA metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006306 | DNA methylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044728 | DNA methylation or demethylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006304 | DNA modification | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006353 | DNA-dependent transcription, termination | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031365 | N-terminal protein amino acid modification | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006498 | N-terminal protein lipidation | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006499 | N-terminal protein myristoylation | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016246 | RNA interference | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006396 | RNA processing | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0007568 | aging | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901605 | alpha-amino acid metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046348 | amino sugar catabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006040 | amino sugar metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006026 | aminoglycan catabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006022 | aminoglycan metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006915 | apoptotic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0009066 | aspartate family amino acid metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042537 | benzene-containing compound metabolic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016051 | carbohydrate biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016052 | carbohydrate catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0007569 | cell aging | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007049 | cell cycle | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0048468 | cell development | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000902 | cell morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000904 | cell morphogenesis involved in differentiation | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007166 | cell surface receptor signaling pathway | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016998 | cell wall macromolecule catabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044036 | cell wall macromolecule metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071554 | cell wall organization or biogenesis | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006520 | cellular amino acid metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044275 | cellular carbohydrate catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0032989 | cellular component morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016043 | cellular component organization | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071840 | cellular component organization or biogenesis | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006073 | cellular glucan metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0051641 | cellular localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044265 | cellular macromolecule catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070727 | cellular macromolecule localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044247 | cellular polysaccharide catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044264 | cellular polysaccharide metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044257 | cellular protein catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034613 | cellular protein localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0071359 | cellular response to dsRNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:1901699 | cellular response to nitrogen compound | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:1901701 | cellular response to oxygen-containing compound | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071446 | cellular response to salicylic acid stimulus | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006032 | chitin catabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006030 | chitin metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016482 | cytoplasmic transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0042742 | defense response to bacterium | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009814 | defense response, incompatible interaction | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046351 | disaccharide biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0046352 | disaccharide catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0031050 | dsRNA fragmentation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009790 | embryo development | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009793 | embryo development ending in seed dormancy | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009553 | embryo sac development | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051649 | establishment of localization in cell | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0045184 | establishment of protein localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0072594 | establishment of protein localization to organelle | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010154 | fruit development | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016458 | gene silencing | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031047 | gene silencing by RNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035195 | gene silencing by miRNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009251 | glucan catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044042 | glucan metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:1901072 | glucosamine-containing compound catabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901071 | glucosamine-containing compound metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046486 | glycerolipid metabolic process | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006650 | glycerophospholipid metabolic process | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010052 | guard cell differentiation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006972 | hyperosmotic response | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042538 | hyperosmotic salinity response | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051701 | interaction with host | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044419 | interspecies interaction between organisms | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006886 | intracellular protein transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0046907 | intracellular transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0042158 | lipoprotein biosynthetic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042157 | lipoprotein metabolic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033036 | macromolecule localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043414 | macromolecule methylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010216 | maintenance of DNA methylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009554 | megasporogenesis | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0051321 | meiotic cell cycle | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0006555 | methionine metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0032259 | methylation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035821 | modification of morphology or physiology of other organism | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0052018 | modulation by symbiont of RNA levels in host | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0052249 | modulation of RNA levels in other organism involved in symbiotic interaction | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009890 | negative regulation of biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0060548 | negative regulation of cell death | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031324 | negative regulation of cellular metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051170 | nuclear import | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051169 | nuclear transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006913 | nucleocytoplasmic transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009312 | oligosaccharide biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009313 | oligosaccharide catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:1901617 | organic hydroxy compound biosynthetic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901615 | organic hydroxy compound metabolic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071702 | organic substance transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0019637 | organophosphate metabolic process | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046488 | phosphatidylinositol metabolic process | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006644 | phospholipid metabolic process | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048236 | plant-type spore development | 1 (1.25%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
GO:0000272 | polysaccharide catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005976 | polysaccharide metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009886 | post-embryonic morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016441 | posttranscriptional gene silencing | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035194 | posttranscriptional gene silencing by RNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010608 | posttranscriptional regulation of gene expression | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010599 | production of lsiRNA involved in RNA interference | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0030422 | production of siRNA involved in RNA interference | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043543 | protein acylation | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0030163 | protein catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0017038 | protein import | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006606 | protein import into nucleus | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006497 | protein lipidation | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008104 | protein localization | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034504 | protein localization to nucleus | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0033365 | protein localization to organelle | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0032446 | protein modification by small protein conjugation | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0070647 | protein modification by small protein conjugation or removal | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0018377 | protein myristoylation | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006605 | protein targeting | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044744 | protein targeting to nucleus | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0015031 | protein transport | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016567 | protein ubiquitination | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0006508 | proteolysis | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0065008 | regulation of biological quality | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0090342 | regulation of cell aging | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0040029 | regulation of gene expression, epigenetic | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009617 | response to bacterium | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010200 | response to chitin | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043331 | response to dsRNA | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009739 | response to gibberellin stimulus | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0010243 | response to organonitrogen compound | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009751 | response to salicylic acid | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009415 | response to water | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009414 | response to water deprivation | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009697 | salicylic acid biosynthetic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009863 | salicylic acid mediated signaling pathway | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009696 | salicylic acid metabolic process | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048316 | seed development | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010016 | shoot system morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044724 | single-organism carbohydrate catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005983 | starch catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005982 | starch metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0090332 | stomatal closure | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010374 | stomatal complex development | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010103 | stomatal complex morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010118 | stomatal movement | 1 (1.25%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0005987 | sucrose catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005985 | sucrose metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0000096 | sulfur amino acid metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006790 | sulfur compound metabolic process | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009627 | systemic acquired resistance | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 1 (1.25%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0005992 | trehalose biosynthetic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005991 | trehalose metabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010026 | trichome differentiation | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010090 | trichome morphogenesis | 1 (1.25%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010050 | vegetative phase change | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009616 | virus induced gene silencing | 1 (1.25%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |